Project Snapshot: CRISPR Cas9
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
Pharma IQ spoke to Bhuvaneish T. Selvaraj, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project.
Have Your Say
Rate this feature and give us your feedback in the comments section below